Henry F. Hoff

6.5k total citations · 2 hit papers
64 papers, 5.3k citations indexed

About

Henry F. Hoff is a scholar working on Surgery, Immunology and Biochemistry. According to data from OpenAlex, Henry F. Hoff has authored 64 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 27 papers in Immunology and 22 papers in Biochemistry. Recurrent topics in Henry F. Hoff's work include Atherosclerosis and Cardiovascular Diseases (25 papers), Antioxidant Activity and Oxidative Stress (22 papers) and Cholesterol and Lipid Metabolism (15 papers). Henry F. Hoff is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (25 papers), Antioxidant Activity and Oxidative Stress (22 papers) and Cholesterol and Lipid Metabolism (15 papers). Henry F. Hoff collaborates with scholars based in United States, Austria and India. Henry F. Hoff's co-authors include Eugene A. Podrez, Stanley L. Hazen, Roy L. Silverstein, Maria Febbraio, David P. Hajjar, David Schmitt, Robert G. Salomon, June O’Neil, John W. Gaubatz and Jonathan D. Smith and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Circulation Research.

In The Last Decade

Henry F. Hoff

64 papers receiving 5.2k citations

Hit Papers

Scavenger Receptors Class A-I/II and CD36 Are the Princip... 2000 2026 2008 2017 2002 2000 250 500 750

Peers

Henry F. Hoff
Rajendra K. Tangirala United States
Eugene A. Podrez United States
Joy S. Frank United States
Martha K. Cathcart United States
Pieter H.E. Groot Netherlands
Vladimir R. Babaev United States
Henry F. Hoff
Citations per year, relative to Henry F. Hoff Henry F. Hoff (= 1×) peers Ganesamoorthy Subbanagounder

Countries citing papers authored by Henry F. Hoff

Since Specialization
Citations

This map shows the geographic impact of Henry F. Hoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry F. Hoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry F. Hoff more than expected).

Fields of papers citing papers by Henry F. Hoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry F. Hoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry F. Hoff. The network helps show where Henry F. Hoff may publish in the future.

Co-authorship network of co-authors of Henry F. Hoff

This figure shows the co-authorship network connecting the top 25 collaborators of Henry F. Hoff. A scholar is included among the top collaborators of Henry F. Hoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry F. Hoff. Henry F. Hoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoppe, George, June O’Neil, Henry F. Hoff, & Jonathan E. Sears. (2004). Products of lipid peroxidation induce missorting of the principal lysosomal protease in retinal pigment epithelium. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1689(1). 33–41. 33 indexed citations
2.
Podrez, Eugene A., George Hoppe, June O’Neil, & Henry F. Hoff. (2003). Phospholipids in oxidized LDL not adducted to apoB are recognized by the CD36 scavenger receptor. Free Radical Biology and Medicine. 34(3). 356–364. 21 indexed citations
3.
Crabb, John W., June O’Neil, Masaru Miyagi, Karen A. West, & Henry F. Hoff. (2002). Hydroxynonenal inactivates cathepsin B by forming Michael adducts with active site residues. Protein Science. 11(4). 831–840. 90 indexed citations
4.
Kunjathoor, Vidya, Maria Febbraio, Eugene A. Podrez, et al.. (2002). Scavenger Receptors Class A-I/II and CD36 Are the Principal Receptors Responsible for the Uptake of Modified Low Density Lipoprotein Leading to Lipid Loading in Macrophages. Journal of Biological Chemistry. 277(51). 49982–49988. 818 indexed citations breakdown →
5.
Podrez, Eugene A., Maria Febbraio, Nader Sheibani, et al.. (2000). Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. Journal of Clinical Investigation. 105(8). 1095–1108. 354 indexed citations
6.
Febbraio, Maria, Eugene A. Podrez, Jonathan D. Smith, et al.. (2000). Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. Journal of Clinical Investigation. 105(8). 1049–1056. 816 indexed citations breakdown →
7.
Podrez, Eugene A., David Schmitt, Henry F. Hoff, & Stanley L. Hazen. (1999). Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. Journal of Clinical Investigation. 103(11). 1547–1560. 412 indexed citations
8.
Salomon, Robert G., Wei Sha, Cynthia J. Brame, et al.. (1999). Protein Adducts of Iso[4]levuglandin E2, a Product of the Isoprostane Pathway, in Oxidized Low Density Lipoprotein. Journal of Biological Chemistry. 274(29). 20271–20280. 48 indexed citations
9.
Podrez, Eugene A., et al.. (1998). Measurement of oxidation in plasma Lp(a) in CAPD patients using a novel ELISA. Kidney International. 54(2). 637–645. 12 indexed citations
10.
O’Neil, June, et al.. (1997). Inactivation of Cathepsin B by Oxidized LDL Involves Complex Formation Induced by Binding of Putative Reactive Sites Exposed at Low pH to Thiols on the Enzyme. Free Radical Biology and Medicine. 23(2). 215–225. 38 indexed citations
11.
Hoppe, George, June O’Neil, Lawrence M. Sayre, & Henry F. Hoff. (1997). Non-conventional modification of low density lipoproteins: chemical models for macrophage recognition of oxidized LDL. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1362(2-3). 103–108. 10 indexed citations
12.
Hoppe, George, et al.. (1997). Macrophage recognition of LDL modified by levuglandin E2, an oxidation product of arachidonic acid. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1344(1). 1–5. 34 indexed citations
13.
Hoff, Henry F. & George Hoppe. (1995). Structure of cholesterol-containing particles accumulating in atherosclerotic lesions and the mechanisms of their derivation. Current Opinion in Lipidology. 6(5). 317–325. 19 indexed citations
14.
Smejkal, Gary B. & Henry F. Hoff. (1994). Filipin staining of lipoproteins in polyacrylamide gels: Sensitivity and photobleaching of the fluorophore and its use in a double staining method. Electrophoresis. 15(1). 922–925. 5 indexed citations
15.
O’Neil, June, et al.. (1994). Lp(a) and premature mortality during chronic hemodialysis treatment. Chemistry and Physics of Lipids. 67-68. 419–427. 14 indexed citations
16.
Smejkal, Gary B. & Henry F. Hoff. (1992). Transverse pore gradient gel electrophoresis of lipoprotein [a] using methylenebisacrylamide gradients. Electrophoresis. 13(1). 102–103. 2 indexed citations
17.
Hoff, Henry F. & June O’Neil. (1988). Extracts of human atherosclerotic lesions can modify low density lipoproteins leading to enhanced uptake by macrophages. Atherosclerosis. 70(1-2). 29–41. 28 indexed citations
18.
Hoff, Henry F., David L. Feldman, & Ross G. Gerrity. (1983). Localization of LDL in Arteries: Improvements in Immunofluorescence Procedures a. Annals of the New York Academy of Sciences. 420(1). 159–164. 4 indexed citations
19.
Heideman, Carol L. & Henry F. Hoff. (1982). Lipoproteins containing apolipoprotein A-I extracted from human aortas. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 711(3). 431–444. 23 indexed citations
20.
Hoff, Henry F., Carol L. Heideman, George P. Noon, & John Stirling Meyer. (1975). Localization of Apo-Lipoproteins in Human Carotid Artery Plaques. Stroke. 6(5). 531–534. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026